Who owns MBX Biosciences, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of MBX from SEC Form 13F filings across 190 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 190 institutions disclosed 55.5M shares of MBX Biosciences, Inc. worth $3.25B — about 114.2% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
190
13F holders
$3.25B
value, 2026 filers
114.2%
of shares outstanding (55.5M sh)
41
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of MBX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 7.4M | $431.9M | 0.0% | 15.2% | +38.4% |
| 2 | Frazier Life Sciences Management, L.P. | 6.7M | $389.9M | 9.7% | 13.7% | 0.0% |
| 3 | WELLINGTON MANAGEMENT GROUP LLP | 5.2M | $302.7M | 0.1% | 10.6% | +3.8% |
| 4 | Paradigm Biocapital Advisors LP | 3.8M | $221.2M | 4.4% | 7.8% | +50.4% |
| 5 | NEA Management Company, LLC | 3.6M | $211.9M | 15.5% | 7.4% | 0.0% |
| 6 | BlackRock, Inc. | 3.5M | $203.6M | 0.0% | 7.2% | +4.5% |
| 7 | ORBIMED ADVISORS LLC | 3.1M | $180.2M | 3.3% | 6.3% | -10.3% |
| 8 | NVP ASSOCIATES, LLC | 2.1M | $125.2M | 44.4% | 4.4% | 0.0% |
| 9 | Polar Capital Holdings Plc | 1.6M | $94.0M | 0.2% | 3.3% | -0.3% |
| 10 | VANGUARD CAPITAL MANAGEMENT LLC | 1.4M | $83.9M | 0.0% | 2.9% | -3.1% |
| 11 | Aaron Wealth Advisors LLC | 1.2M | $68.9M | 3.4% | 2.4% | +0.7% |
| 12 | Driehaus Capital Management LLC | 1.0M | $59.4M | 0.4% | 2.1% | -4.2% |
| 13 | Kynam Capital Management, LP | 934,799 | $54.8M | 3.0% | 1.9% | 0.0% |
| 14 | EVENTIDE ASSET MANAGEMENT, LLC | 873,492 | $51.2M | 0.7% | 1.8% | 0.0% |
| 15 | STATE STREET CORP | 861,502 | $50.5M | 0.0% | 1.8% | -0.3% |
| 16 | GEODE CAPITAL MANAGEMENT, LLC | 841,043 | $49.3M | 0.0% | 1.7% | +8.8% |
| 17 | Parkman Healthcare Partners LLC | 716,542 | $42.0M | 3.8% | 1.5% | -10.5% |
| 18 | Woodline Partners LP | 653,972 | $38.3M | 0.1% | 1.3% | -27.3% |
| 19 | TCG Crossover Management, LLC | 650,000 | $38.1M | 1.1% | 1.3% | 0.0% |
| 20 | Deep Track Capital, LP | 640,000 | $37.5M | 0.6% | 1.3% | -63.1% |
| 21 | PRICE T ROWE ASSOCIATES INC /MD/ | 621,624 | $36.4M | 0.0% | 1.3% | -23.7% |
| 22 | GOLDMAN SACHS GROUP INC | 425,555 | $24.9M | 0.0% | 0.9% | -7.3% |
| 23 | BRAIDWELL LP | 398,951 | $23.4M | 1.0% | 0.8% | -43.9% |
| 24 | Cormorant Asset Management, LP | 375,000 | $22.0M | 1.5% | 0.8% | -31.8% |
| 25 | VANGUARD PORTFOLIO MANAGEMENT LLC | 323,459 | $19.0M | 0.0% | 0.7% | -6.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.